Becton, Dickinson and Company is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
The BD Life Sciences segment delivers innovative solutions from discovery to diagnosis, continually advancing science and clinical outcomes across infectious disease and cancer. Offerings include preanalytical solutions for sample management, immunology research solutions, including flow cytometry and multiomics tools, microbiology and molecular diagnostics, lab automation and informatics solutions, as well as differentiated reagents and assays. The segment serves research institutions, industrial and reference laboratories, blood banks, hospitals and clinics, alternate site healthcare, public health agencies, academic and government institutions, as well as pharmaceutical and biotech companies.The BD Interventional segment focuses on developing innovative surgical, endovascular, urological and critical care interventions that not only meet clinical needs, but also deliver value to health systems and improve patients’ lives. This segment serves hospitals and clinics, physicians, ambulatory surgery centers, nurses and consumers.BD was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ. The company has 65,000 employees worldwide and in 2017, BD welcomed C. R. Bard and its products into the BD family.